Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasGeneral adult psychiatry — psychotic disorders

Psych Vivas · General adult psychiatry — psychotic disorders

Delusional disorder — structured clinical viva

Fellowship viva on somatic delusional disorder vs schizophrenia, engagement without collusion, iatrogenic harm prevention, antipsychotic plan, and evidence limits.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. A GP has labelled a 51-year-old woman ‘paranoid schizophrenia’ because she has a fixed 2-year belief that her body is infested with parasites. She brings bags of ‘specimens.’ No voices, no thought disorder, continues part-time work, and has had three unnecessary dermatology procedures. Discuss diagnosis, engagement, liaison, and treatment.

Interpretation

Reveal interpretation

Working diagnosis. Delusional disorder, somatic subtype (infestation belief), duration years, no prominent hallucinations, relatively preserved occupational function — partial psychosis rather than multi-domain schizophrenia. Differential includes organic skin disease (rule out once), substance use, BDD/illness anxiety with poor insight, and late medical/neurocognitive disease if new cognitive signs appear.[1][2]

Why not schizophrenia. Absence of broader Criterion A (prominent voices, disorganisation, negative symptom syndrome) and relatively preserved role function outside the somatic theme favour delusional disorder over schizophrenia.[2]

Structured viva answers

Reveal structured answers

Engagement. Validate distress and sleep disruption; do not collude (“yes, parasites”) and do not ridicule specimens. Negotiate shared goals: itch control, sleep, reduce harmful self-treatments, coordinated care. Frame medication as reducing mental pressure and preoccupation so she can function — not as proof the belief is false on day one.[6][4]

Liaison and harm prevention. One thorough medical/dermatology review to exclude genuine pathology, then psychiatric leadership of the care plan to prevent endless biopsies/procedures. Agree a letter framework with GP/dermatology: investigate red flags, avoid non-indicated invasive interventions.[5][4]

Pharmacotherapy. Offer SGA trial with monitoring — e.g. aripiprazole 5–10 mg daily toward 10–15 mg, or risperidone 1–2 mg titrating carefully, or olanzapine 5–10 mg if sedation/itch sleep disruption dominates, with metabolic/EPS/prolactin/ECG-risk monitoring as indicated. Historical pimozide is an exam pearl with QTc caution, not automatic modern first line. State Cochrane: sparse high-quality DD-specific RCTs.[3][5][6][4]

Success metrics. Reduced specimen-collecting, less self-excoriation/self-treatment, better sleep, fewer emergency dermatology attendances — belief may persist partially.[6][1]

Risks. Suicide if despair when belief falters; iatrogenic medical harm; antipsychotic side effects; disengagement if alliance broken.[4]

References

  1. [1]Opjordsmoen S Delusional disorder as a partial psychosis Schizophr Bull, 2014.PMID 24421383
  2. [2]González-Rodríguez A, Seeman MV Differences between delusional disorder and schizophrenia: A mini narrative review World J Psychiatry, 2022.PMID 35663297
  3. [3]Skelton M, Khokhar WA, Thacker SP Treatments for delusional disorder Cochrane Database Syst Rev, 2015.PMID 25997589
  4. [4]Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders Aust N Z J Psychiatry, 2016.PMID 27106681
  5. [5]González-Rodríguez A, Monreal JA, Natividad M, et al. Seventy Years of Treating Delusional Disorder with Antipsychotics: A Historical Perspective Biomedicines, 2022.PMID 36552037
  6. [6]Manschreck TC, Khan NL Recent advances in the treatment of delusional disorder Can J Psychiatry, 2006.PMID 16989110